Is there a difficulty in maintaining haemoglobin target levels in pre-dialysis patients treated with erythropoiesis-stimulating agents? Eugènia Santacana-Juncosa, Núria Padullés-Zamora, Ariadna Padullés-Zamora, Dolors Comas-Sugrañes, Lorena Santulario-Verdú, Núria Sanmartí-Martínez, Alberto Martínez-Castelao

Good practice guidelines on the use of erythropoiesis-stimulating agents in 2011 Pérez-Oliva Díaz, Jorge F. Perez-Oliva Diaz

The relationship between comorbidity, anemia and response to erythropoiesis-stimulating agents in chronic hemodialysis Sara Anaya Fernández, Rivera, Sánchez de la Nieta, Carreño, Vozmediano, Alcaide, Arambarri, Nieto, Caparrós, Ferreras